Treatment and Biomarker Testing Patterns,Treatment Outcomes in a/m NSCLC With and Without Actionable Genomic Alterations

Clinical trial NCT06245837 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06245837
Sponsor: AstraZeneca
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL

Non-small-cell Lung Cancer

Start date: 2024-03-20
Primary completion: 2026-06-30
Enrollment: 1500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.